Aug 8 (Reuters) - A shortage of intravenous and

injectable saline solutions in the United States has now been

resolved, U.S. Food and Drug Administration commissioner Martin

Makary said on Friday.

The shortage partly stems from Baxter International's ( BAX )

North Carolina plant getting damaged in Hurricane Helene

last year.

At that time, the Marion, North Carolina site was producing

60% of the nation's supply of IV fluids and peritoneal dialysis

solutions, amounting to 1.5 million bags daily, according to the

American Hospital Association.

A shortage of IV fluids, which provide nutrients to the body

or replenish fluids lost due to injury or illness, had forced

hospitals to curtail elective procedures.